Table 3.
Network pharmacology-based investigation of multi-targeted effects or molecular mechanisms of some herbal medicines or their derived products.
| Sr. No. | Medicinal Plant/Traditional Formulations | Phytoconstituents | Biomolecular Targets/Genes | Therapeutic Role | Mechanism of Action | References |
|---|---|---|---|---|---|---|
| 1 | Boerhaavia diffusa | Apigenin, ferulic acid and quercetin | ABCA1, AKT1, MMP9, LEPR, AKR1C3, KDR, PPARs, ESR1, ARNT, PON2, SESN2, IRS1, ILs, MAPKs, CAPSs, NOS, etc. | Nephroprotective | Reduction of oxidative and inflammatory stress, glomerulonephritis, reduction of vascular rigidity in hypertension | [33] |
| 2 | Tinospora cordifolia | Gallic acid and rutin | CASPs, MAPKs, NOS, PRNP, CTGF, SREBF1, and JUN | Nephroprotective | Reduction of oxidative and inflammatory stress, glomerulonephritis | [33] |
| 3 | Momordica charantia | Linalool, quercetin, gallic acid, apiole, ferulic acid, caffeic acid, limonene and catechin | NOS, ILs, CASPs, MAPKs, G6PD, MAPK1, MAPK3, MMPs, PTGS2, PON1, ILs, AKT1, JUN, MMPs, PPARG, TP53, etc. | Diabetic nephropathy | Amelioration in endothelial dysfunction, fatty liver disease, diabetes mellitus, acute kidney injury, fibrosis, hypertensive disease, obesity, etc. | [34] |
| 4 | - | Quercetin and kaempferol | TNF, JUN, IL6, STAT3, MAPK1, and MAPK3 | Acne Vulgaris | Anti-inflammatory effect and regulate the excessive lipogenesis in sebaceous glands via different signaling pathways | [104] |
| 5 | Gelsemium elegans | Gelegamine E, gelsesyringalidine, humantenine, gelsedine, 19-z-akuammidine, gelegamine B, tabersonine, koumine, gelsemine | MAPK3, HSP90AA1, JUN, EGFR, CDK1, TNF, CCND1, ESR1, PRKACA, CCNA2, CDC25C, CDK2, CCNB1, AR, CREBBP, AURKA, CDC25A, CHEK1, BCL2L1, and PIK3CD | Anti-cancer | Pathways in cancer, cell cycle, and colorectal cancer | [105] |
| 6 | Danning Tablets (A polyherbal formulation) | Quercetin, ß-sitosterol, luteolin, kaempferol, supraene, curcumenolactone C, and stigmasterol | IL6, MAPK8, VEGFA, CASP3, ALB, APP, MYC, PPARG, and RELA | Nonalcoholic Fatty Liver Disease | Lipid metabolism, inflammation, oxidation, insulin resistance (IR), atherosclerosis, and apoptosis | [106] |
| 7 | Panax notoginseng | Mandenol, beta-sitosterol, stigmasterol, ginsenoside rh2, ginsenoside f2, quercetin | VEGFA, MMP-9, MMP-2, FGF2, and COX-2 | Diabetic Retinopathy | Intervention of angiogenesis, inflammation, and apoptosis | [107] |
| 8 | Angelica sinensis | Isorhamnetin, jaranol, 3,9-di-O-methylnissolin, mairin, formononetin, isoflavanone, quercetin, kaempferol and (3R)-3-(2-hydroxy-3,4-dimethoxyphenyl)chroman-7-ol | VEGFA, TP53, IL-6, TNF, MARK1 | Diabetic nephropathy | Apoptosis, oxidative stress, inflammation, glucose, and lipid metabolism processes | [108] |
| 9 | Caesalpinia pulcherima | Gallic acid, catechin, ellagic acid, quercetina and cyanidin 3-glucoside | ESR-1, ESR-2, ESRRA, MET, VEGF, FGF, PI3K, PDK-1, MAPK, PLK-1, NEK-2, and GRK | Breast cancer | Breast cancer, endometrial cancer, and osteoporosis, estrogen signaling pathway, prolactin signaling pathway, thyroid hormone signaling pathway, and relaxin signaling pathway | [109] |
| 10 | Chinese herbal formula Shenyi (SY) | Moupinamide, quercetin, eriodictyol, hesperetin, formononetin, palmatine, norlobeline, taxifoline, sinoacutine, beta-sitosterol, kaempferol, stigmasterol, acacetin, linarin, and isovitexin | AKT1, TNF, IL6, TP53, VEGFA, EGFR, CASP3, JUN, IL1B, MYC, ESR1, HIF1A, HSP90AA1, EGF, PTGS2, MMP9, and CCND1 | Diabetic nephropathy | Glomerulosclerosis, nephrotoxicity, oxidative stress, inflammation, and hyperglycemia, inhibit RhoA/Rho kinase to ameliorate kidney injury and decrease fibrosis | [110] |
| 11 | Jasminum grandiflorum L. | Quercetin, kaempferol, myricitrin, laricitrin 3-o-glucoside, myricetin 3-xyloside, reynoutrin, kaempferitrin, oleuropein, multifloroside, isoquercitrin, oleuropein glucoside, verbascoside | MKK4, MKK7, I-CAM 1, IL-6, TNF, TRAF2, PI3K-Akt, MAPK, EGFR, | Nephroprotective | Reduction in tubular cell lining vacuolation and intratubular cast deposition in the renal tubules, oxidative stress, inflammation, and apoptosis | [111] |